Christine Duvauchelle

Dr. Christine Duvauchelle

University of Texas at Austin

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2009 in Behavioural Brain Research
Verified
Journal Article
Closed access
AAA Ahrens
A Ahrens
SMS Ma
S Ma
EME Maier
E Maier
CDChristine Duvauchelle
Christine Duvauchelle
TST Schallert
T Schallert

1 April 2005 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
DJDouglas C. Jones
Douglas C. Jones
CDChristine Duvauchelle
Christine Duvauchelle
AIAiko Ikegami
Aiko Ikegami
COChris Olsen
Chris Olsen
SLSerrine S. Lau
Serrine S. Lau
TMTerrence J. Monks
Terrence J. Monks
The selective serotonergic neurotoxicity of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) depends on their systemic metabolism. We have recently shown that inhibition of brain endothelial cell γ-glutamyl transpeptidase (γ-GT) potentiates the neurotoxicity of both MDMA and MDA, indicating that metabolites that are substrates for this enzyme contribute to the neurotoxicity. Consistent with this view, glutathione (GSH) and N-acetylcysteine conjugates of α-methyl dopamine (α-MeDA) are selective neurotoxicants. However, neurotoxic metabolites of MDMA or MDA have yet to be identified in brain. Using in vivo microdialysis coupled to liquid chromatography-tandem mass spectroscopy and a high-performance liquid chromatography-coulometric electrode array system, we now show that GSH and N-acetylcysteine conjugates of N-methyl-α-MeDA are present in the striatum of rats administered MDMA by subcutaneous injection. Moreover, inhibition of γ-GT with acivicin increases the concentration of GSH and N-acetylcysteine conjugates of N-methyl-α-MeDA in brain dialysate, and there is a direct correlation between the concentrations of metabolites in dialysate and the extent of neurotoxicity, measured by decreases in serotonin (5-HT) and 5-hydroxyindole acetic (5-HIAA) levels. Importantly, the effects of acivicin are independent of MDMA-induced hyperthermia, since acivicin-mediated potentiation of MDMA neurotoxicity occurs in the context of acivicin-mediated decreases in body temperature. Finally, we have synthesized 5-(N-acetylcystein-S-yl)-N-methyl-α-MeDA and established that it is a relatively potent serotonergic neurotoxicant. Together, the data support the contention that MDMA-mediated serotonergic neurotoxicity is mediated by the systemic formation of GSH and N-acetylcysteine conjugates of N-methyl-α-MeDA (and α-MeDA). The mechanisms by which such metabolites access the brain and produce selective serotonergic neurotoxicity remain to be determined.

1 September 2010 in Behavioural Brain Research
Verified
Journal Article
Closed access
SMSean T. Ma
Sean T. Ma
EMEsther Y. Maier
Esther Y. Maier
AAAllison M. Ahrens
Allison M. Ahrens
TSTimothy Schallert
Timothy Schallert
CDChristine Duvauchelle
Christine Duvauchelle

1 June 2008 in Neuroscience
Verified
Journal Article
Closed access
EHE.C. Howard
E.C. Howard
CSC.J. Schier
C.J. Schier
JWJ.S. Wetzel
J.S. Wetzel
CDChristine Duvauchelle
Christine Duvauchelle
RGR.A. Gonzales
R.A. Gonzales

23 May 2013 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
AAAllison M. Ahrens
Allison M. Ahrens
CNCameron W. Nobile
Cameron W. Nobile
LPLindsay E. Page
Lindsay E. Page
EMEsther Y. Maier
Esther Y. Maier
CDChristine Duvauchelle
Christine Duvauchelle
TSTimothy Schallert
Timothy Schallert

26 August 2011 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
EMEsther Y. Maier
Esther Y. Maier
MAMohamed Abdalla
Mohamed Abdalla
AAAllison M. Ahrens
Allison M. Ahrens
TSTimothy Schallert
Timothy Schallert
CDChristine Duvauchelle
Christine Duvauchelle